|
References Adlercreutz CHT, Goldin BR, Gorbach SL, and Fotsis T. Soybean phytoestrogen intake and cancer risk. J. Nutr. 1995; 125: 757S-770S. Akiyama T, Ishida J, Nakagawa S, Ogawara H, Watanabe S, Itoh N, Shibuya M, Fukami Y. Genistein, a specific inhibitor of tyrosine-specific protein kinases. J Biol Chem. 1987; 262:5592-5595. Ambrose A M, Robbins DJ, Deeds F. Comparative toxicities of quercetin and quercitrin. J. Am. Pharm. Assoc., 1951; 41: 119-122. Ander C, Eliezer H. Genistein as an inducer of tumor cell differentiation: Possible mechanisms of action. Department of surgical oncology and department of genitics.1995; 208: 109-115. Barnes S, Grubbs C, Setchell KD, Carlson J. Soybeans inhibit mammary tumors in models of breast cancer. Prog Clin Biol Res. 1990; 347:239-253. Barnes S, Peterson TG. Biochemical targets of the isoflavone genistein in tumor cell lines. Proc Soc Exp Biol Med. 1995; 208:103-108. Barnes S. Effect of genistein on in vitro and in vivo models of cancer. J Nutr. 1995; 125: 777S-783S. Barnes S, Peterson G, Grubbs C, Setchell K. Potential role of dietary isoflavones in the prevention of cancer. Adv. Exp. Med. Biol., 1998; 354: 135-147. Bates S, Bonetta L, MacAllan D, Parry D, Holder A, Dickson C, Peters G. CDK6 (PLSTIRE) and CDK4 (PSK-J3) are a distinct subset of the cyclin-dependent kinases that associate with cyclin D1.Oncogene.1994; 9:71-79. Becker FF. Inhibition of spontaneous hepatocarcinogenesis in C3H/HeN mice by Edi Pro A, an isolated soy protein. Carcinogenesis.1981; 2:1213-1214. Bishop JM. Cellular oncogenes and retroviruses. Annu Rev Biochem.1983; 52:301-354. Bjeldanes LF, Chang GW. Mutagenic activity of quercetin and related compounds. Science. 1977; 197:577-578. Cardon-Cardo C, Mutations of cell cycle regulators. Biological and clinical implications for human neoplasis. Am. J. Pathol.1995; 147: 545-560. Ek B, Westermark B, Wasteson A, Heldin CH. Stimulation of tyrosine-specific phosphorylation by platelet-derived growth factor. Nature. 982; 295:419-420. Fournier DB, Erdman JW, Gordon GB. Soy, its components and cancer prevention: a review of the in vitro, animal and human data. Cancer Epidemiol. Biomarkers Prev., 1998; 7: 1055-1065. Hartwell LH, Weinert TA. Checkpoints: controls that ensure the order of cell cycle events. Science.1989; 246:629-634. Hosokawa N, Hosokawa Y, Sakai T, Yoshida M, Marui N, Nishino H, Kawai K, Aoike A. Inhibitory effect of quercetin on the synthesis of a possibly cell-cycle-related 17-kDa protein, in human colon cancer cells. Int J Cancer.1990; 45:1119-1124. Kato J, Matsushime H, Hiebert SW, Ewen ME, Sherr CJ. Direct binding of cyclin D to the retinoblastoma gene product (pRb) and pRb phosphorylation by the cyclin D-dependent kinase CDK4.Genes Dev. 1993; 7:331-342. Kao GD, McKenna G, Maity A, Blank K, and Muschel RJ. Cyclin B1 availability is a rate-limiting component of the radiation-induced G2 delay in Hela cells. Cancer Research.1997; 57: 753-758. Kim JH, Kim SH, Alfieri AA, Young CW. Quercetin, an inhibitor of lactate transport and a hyperthermic sensitizer of HeLa cells.Cancer Res. 1984 Jan; 44:102-106. Cohen LA. Zhao ZB. Pittman, J. A. Sciemca. Effect of intact and isoflavone-depleted soy protein on NMU-induced rat mammary tumorigenesis. Carcinogenesis.2000; 21: 929-935. MacGregor JT.Genetic toxicology of dietary flavonoids. Prog Clin Biol Res. 1986; 206:33-43. Maity A, Mckenna WG, Muschel RJ. The molecular basis for cell cycle delays following ionizing radiation: a review. Radiotherapy and Oncology. 994; 31: 1-13. Messina M, Barnes S. The role of soy products in reducing risk of cancer. J Natl Cancer Inst. 1991; 83:541-546. Messina MJ, Persky V, Setchell KD, Barnes S. Soy intake and cancer risk: a review of the in vitro and in vivo data. Nutr Cancer.1994; 21:113-131. Meyerson M, Harlow E. Identification of G1 kinase activity for cdk6, a novel cyclin D partner. Mol Cell Biol. 1994; 14:2077-2086. Morgan, DO. Principles of CDk regulation. Nature. 1995; 374: 131-134 Murray AW. Creative blocks: cell-cycle checkpoints and feedback controls. Nature.1992; 359: 599-604. Pines J. Arresting developments in cell-cycle control. Trends Biochem. Sci. 1994; 19: 143-145. Pine J, Hunter T. Human cyclin A and cyclin B are differentially located in the cell and undergo cell cycle-dependent nuclear transport. J. Cell Biol. 1991; 115: 1-17. Stuart W, Young, Fan Q, Anthony H, Jonathan L and Richard A. Gadolinium(Ⅲ)texaphyrin: A tumor selective radiation sensitizer that is detectable by MRI. Proc. Natl. Acad. Sci. USA.1996; 93: 6610-6615. Suolinna EM, Buchsbaum RN, Racker E. The effect of flavonoids on aerobic glycolysis and growth of tumor cells. Cancer Res. 1975; 35:1865-1872. Troll W, Wiesner R, Shellabarger CJ, Holtzman S, Stone JP. Soybean diet lowers breast tumor incidence in irradiated rats. Carcinogenesis.1980; 1:469-472. Ushiro H, Cohen S. Identification of phosphotyrosine as a product of epidermal growth factor-activated protein kinase in A-431 cell membranes. J Biol Chem. 1980; 255:8363-8365. Wang Y, Yaping E, Zhang X, Lebwohl M, DcLco V and Wei H. Inhibition of ultraviolet B (UVB)-induced c-fos and c-jun expression in vivo by a tyrosine kinase inhibitor genistein. Carcinogenesis.1998; 19: 649-654. Weiss G R, in Clinical Oncology, ed. Weiss G R.(Appleton & Lange, Norwalk, CT)1993; pp74-88. Yoshida M, Sakai T, Hosokawa N, Marui N, Matsumoto K, Fujioka A, Nishino H, Aoike A. The effect of quercetin on cell cycle progression and growth of human gastric cancer cells. FEBS Lett.1990; 260:10-13. Yoshizumi M, Nobuyuki M, Akira A. Genistein arrests cell cycle progression at G2-M. Cancer Research.1993; 53: 1328-1331. Young SW, Qing F, Harriman A, Sessler JL, Dow WC, Mody TD, Hemmi GW, Hao Y, Miller RA. Gadolinium(III) texaphyrin: a tumor selective radiation sensitizer that is detectable by MRI. Proc Natl Acad Sci USA. 1996; 93:6610-6615. Zhu W Y, Jones C S, Kiss A, Matsukuma K, Amin S and De Luca L M. Retinoic acid inhibition of cell cycle progression in MCF-7 human breast cancer cells. Experimental cell research. 1997; 234: 293-299.
|